Cetera Advisors LLC Reduces Holdings in PMI

BusinessPMI by 2FIRSTS.ai

Nov.20.2023

Cetera Advisors LLC Reduces Holdings in PMI

Cetera Advisors LLC reduces its holdings in Philip Morris International (PMI) by 0.2% in the second quarter.

According to a report cited by TickerReport on November 16, investment consultancy firm Cetera Advisors LLC reduced its stake in Philip Morris International (PMI) by 0.2% during the second quarter. After selling 288 shares, Cetera now holds a total of 115,563 PMI shares, valued at approximately $11,281,000.

References:

[1] Cetera Advisors LLC Sells 288 Shares of Philip Morris International Inc. (NYSE:PM)

Also Read:

[1] Czech Republic Implements Ban on Flavored Tobacco Products

[2] Brazilian Tobacco Industry Supports Proposed E-cigarette Regulation Law

[3] Philip Morris Philippines Granted Partial Tax Refund on VAT

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

Product | KT&G Brings LOOP Nicotine Pouches to South Africa, Supporting ASF’s Expansion Across Africa

Product | KT&G Brings LOOP Nicotine Pouches to South Africa, Supporting ASF’s Expansion Across Africa

KT&G has introduced nicotine pouch brand LOOP in South Africa, expanding its modern oral nicotine portfolio. Developed by Swedish company Another Snus Factory (ASF), LOOP is a tobacco-free nicotine pouch brand. KT&G and U.S. tobacco company Altria previously participated in ASF’s strategic development, and the South Africa launch represents a further step in LOOP’s international expansion.

Product | JT Upgrades with2 Infused Tobacco Capsules With Double-Size BIG PACK

Product | JT Upgrades with2 Infused Tobacco Capsules With Double-Size BIG PACK

Japan Tobacco Inc. (JT) announced that it will introduce a BIG PACK version of all five tobacco capsule variants designed for its with2 infused tobacco system. Scheduled for release in Japan on August 4, 2026, the refreshed packaging doubles the contents from five capsules and one cartridge to ten capsules and two cartridges while maintaining the same flavors and formulations

Jun.26 by 2Firsts Perspectives

FDA Tobacco Proposal Signals Full-Chain Compliance Test for Global E-Cigarette Supply Chains

FDA Tobacco Proposal Signals Full-Chain Compliance Test for Global E-Cigarette Supply Chains

FDA’s proposed foreign tobacco establishment registration and product listing rule remains unfinished, but Accorto told 2Firsts it reflects a shift toward structured oversight similar to medical device and pharmaceutical compliance frameworks. For Chinese and global e-cigarette suppliers, U.S. market access is moving beyond product authorization toward full-chain compliance covering manufacturing, documentation, import control, distribution, retail and marketing discipline.

FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions

FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions

The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.

Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products

Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products

Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.

Former FDA Scientist Questions ZYN Review Over Pouch Material and Microplastic Risk

Former FDA Scientist Questions ZYN Review Over Pouch Material and Microplastic Risk

A former FDA toxicologist has questioned whether the agency fully assessed the material used in ZYN nicotine pouches before authorizing them for sale, raising concerns over possible microplastic exposure, according to STAT and The Examination.

Related Topics

Related Read

Product | KT&G Brings LOOP Nicotine Pouches to South Africa, Supporting ASF’s Expansion Across Africa

Product | KT&G Brings LOOP Nicotine Pouches to South Africa, Supporting ASF’s Expansion Across Africa

Product | JT Upgrades with2 Infused Tobacco Capsules With Double-Size BIG PACK

Product | JT Upgrades with2 Infused Tobacco Capsules With Double-Size BIG PACK

2Firsts Perspectives

FDA Tobacco Proposal Signals Full-Chain Compliance Test for Global E-Cigarette Supply Chains

FDA Tobacco Proposal Signals Full-Chain Compliance Test for Global E-Cigarette Supply Chains

FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions

FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions

Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products

Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products

Former FDA Scientist Questions ZYN Review Over Pouch Material and Microplastic Risk

Former FDA Scientist Questions ZYN Review Over Pouch Material and Microplastic Risk